Montelukast Chewable Tablets 4 mg (Montelukast Sodium)

Adult dose

Adults and adolescents aged 15 and older: Take 10 mg of montelukast orally once daily. 10 mg orally disintegrating film: Place 10 mg on the tongue, let it dissolve, and take it without water. This medication should be taken once daily; asthma patients should take it in the evening, while allergic rhinitis patients can determine the dosing time according to their condition. For patients with both asthma and allergic rhinitis: Take 1 tablet, 1 pack, or 1 film once daily in the evening.

Child dose

Children aged 6-14 years: Chew 5 mg of montelukast once daily. 5 mg oral tablet: Place 5 mg on the tongue, let it dissolve, and take it without water. 5 mg orally disintegrating tablet.

This medication contains the artificial sweetener aspartame, which is broken down in the body to phenylalanine. Therefore, patients with the hereditary disease phenylketonuria should not take this medication. Additionally, this medication contains lactose; patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not use this medication. While this medication helps alleviate asthma or allergic rhinitis symptoms, it is not a treatment used during acute asthma attacks. Therefore, individuals with acute symptoms should always have appropriate emergency medications on hand. During treatment, rare but serious vascular symptoms such as eosinophilia may occur; thus, a doctor should carefully monitor for skin rashes, worsening pulmonary symptoms, heart problems, or neuropathy. It is advisable to avoid taking this medication concurrently with aspirin or non-steroidal anti-inflammatory drugs, particularly for patients with hypersensitivity to aspirin. Safety has been confirmed in clinical trials for children, adolescents, and adults; however, safety and efficacy have not been established in infants under 6 months of age. Women who are pregnant or breastfeeding should consult with a physician before taking this medication, and it should only be used when clearly necessary. In case of overdose, there is no specific antidote, so general symptomatic treatment and clinical monitoring are necessary, and immediate medical attention should be sought if symptoms occur. This medication is sensitive to light, so it should be opened just before use, and it is best taken within 15 minutes after preparation. If neuropsychiatric symptoms such as anxiety, depression, hallucinations, or sleep disturbances occur during treatment, immediate consultation with a physician is required. Do not arbitrarily reduce or discontinue other asthma treatments while taking this medication, and always follow a doctor's instructions. Finally, keep this medication out of the reach of children and be careful not to transfer it to another container.

Serious side effects

Urticaria, toxic epidermal necrolysis, Stevens-Johnson syndrome, angioedema, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin abnormal reactions, shortness of breath or difficulty breathing, asthma attack, respiratory problems with cough and fever, jaundice (yellowing of the skin or eyes)

Mild side effects

• Weakness/fatigue
• fever
• abdominal pain
• trauma
• indigestion
• infectious gastroenteritis
• toothache
• dizziness
• headache
• nasal congestion

This medication is sensitive to moisture and light, so it should be stored in a dry, dark place. A storage temperature between 1 and 30 degrees Celsius is recommended. Additionally, it must be kept in a tightly sealed container to maintain its efficacy.

Appearance

Pink, oval-shaped, chewable tablet that is convex on both sides

Package unit

28 tablets/PTP (7 tablets/PTP x 4)